IA
RIGL icon

IFP Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

IFP Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Sell
2,610
-306
-10% -$9.44K ﹤0.01% 1971
2026
Q1 		$78.8K Buy
2,916
+652
+29% +$21.9K ﹤0.01% 1987
2025
Q4 		$97K Buy
2,264
+405
+22% +$15.3K ﹤0.01% 1811
2025
Q3 		$52.7K Buy
+1,859
New +$55.6K ﹤0.01% 2050
2025
Q2 		– Hold
0
– – – 4569
2025
Q1 		– Sell
-1
Closed -$17 – 4577
2024
Q4 		$17 Buy
+1
New +$19 ﹤0.01% 4477
2024
Q3 		– Sell
-1,000
Closed -$807 – 3423
2024
Q2 		$807 Buy
1,000
+900
+900% +$9.42K ﹤0.01% 3023
2024
Q1 		$1.48K Sell
100
-98
-49% -$1.32K ﹤0.01% 2770
2023
Q4 		$2.86K Hold
198
– – ﹤0.01% 2583
2023
Q3 		$2.13K Hold
198
– – ﹤0.01% 2817
2023
Q2 		$2.55K Sell
198
-3
-1% -$41 ﹤0.01% 2796
2023
Q1 		$6.54K Sell
201
-1
-0.5% -$16 ﹤0.01% 2465
2022
Q4 		$8K Sell
202
-1
-0.5% -$9 ﹤0.01% 3550
2022
Q3 		$8K Hold
203
– – ﹤0.01% 3797
2022
Q2 		$8K Hold
203
– – ﹤0.01% 3550
2022
Q1 		$8K Sell
203
-3
-1% -$81 ﹤0.01% 3549
2021
Q4 		$6K Hold
206
– – ﹤0.01% 2429
2021
Q3 		$9K Sell
206
-10
-5% -$394 ﹤0.01% 2333
2021
Q2 		$8K Buy
216
+31
+17% +$1.17K ﹤0.01% 2304
2021
Q1 		$6K Buy
185
+65
+54% +$2.57K ﹤0.01% 2363
2020
Q4 		$4K Buy
120
+10
+9% +$290 ﹤0.01% 2425
2020
Q3 		$2K Hold
110
– – ﹤0.01% 2509
2020
Q2 		$2K Hold
110
– – ﹤0.01% 2424
2020
Q1 		$2K Buy
+110
New +$2.34K ﹤0.01% 2396
2019
Q4 		– Sell
-50
Closed -$1.03K – 3077
2019
Q3 		$1K Buy
+50
New +$1.03K ﹤0.01% 2918
2019
Q1 		– Sell
-50
Closed -$1K – 3208
2018
Q4 		$1K Buy
+50
New +$1.41K ﹤0.01% 3369

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IFP Advisors's RIGL Position: Q2 2026 in Review

IFP Advisors reduced its Rigel Pharmaceuticals (RIGL) stake by 10% in Q2 2026, selling an estimated $9.44K and leaving 2,610 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #1971.

IFP Advisors first reported a position in RIGL in Q4 2018 and has held it in 25 quarters since. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • IFP Advisors held 2,610 shares of Rigel Pharmaceuticals worth $102K as of Q2 2026.
  • IFP Advisors sold 306 Rigel Pharmaceuticals shares in Q2 2026, an estimated $9.44K.
  • Rigel Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #1971 holding.
  • IFP Advisors first reported a position in Rigel Pharmaceuticals in Q4 2018 and has held it in 25 quarters since.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.